ZIM Laboratories Completes Full Subsidiary Capital Infusion in ZIM Scientific Office
Zim Laboratories Ltd 路 Others (Uncategorized) 路 16 Sept 2026, 1:21 am
ZIM Laboratories Completes Full Subsidiary Capital Infusion in ZIM Scientific Office ZIM Laboratories Limited announced that its wholly owned subsidiary, ZIM Laboratories Limited FZE, has completed the full approved equity investment in step-down subsidiary ZIM Scientific Office LLC. Following prior disclosures on 28th Mar'25 and 7th Aug'25 regarding planned investments of AED 4,66,000 and AED 4,50,000, respectively, the entire approved amount has now been infused into ZIM SO's share capital. Post-investment, ZIM FZE continues to retain a 100% shareholding in ZIM SO.
Original exchange filing (PDF)
More announcements from Zim Laboratories Ltd
- Transcript of Q2 & H1FY27 Earnings Conference Call 路 12 Nov 2026
- Please find enclosed the disclosure pertaining to the audio recording of Q2 & H1 FY27 Earnings Conference Call. 路 05 Nov 2026
- Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed the Earnings Presentation for Q2 & H1 FY27. 路 05 Nov 2026
- Please find enclosed the financial results for the quarter and half year ended 30th September 2026 路 04 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today, .... 路 04 Nov 2026
- Zim Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 04 Nov 2026
- We wish to inform you that Q2 & H1FY27 Earnings Conference Call is scheduled to be held on Thursday, 05th November, 2026 at 11:00 a.m. IST. 路 31 Oct 2026
- ZIM Laboratories Limited has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 04 Nov 2026
